Your institution may have access to this item. Find your institution then sign in to continue.
Title
Keeping faith in gene manipulation.
Abstract
Asserts that good reasons exist for revising the way the gene therapy experiments receive public scrutiny, but such revision must be done sensitively. The controversial role in the scientific community of the Recombinant DNA Advisory Committee (RAC) of the US National Institutes of Health (NIH); The RAC's reputation for effective oversight; Need to revise the RAC sensitively, in order not to undermine public acceptance of the field.